We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

107 hedge funds and large institutions have $744M invested in Rocket Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 28

31% more call options, than puts

Call options by funds: $430K | Put options by funds: $327K

2.49% more ownership

Funds ownership: 94.38% → 96.87% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

11% less funds holding

Funds holding: 120 → 107 (-13)

37% less capital invested

Capital invested by funds: $1.18B → $744M (-$432M)

46% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 28

Holders
107
Holders Change
-13
Holders Change %
-10.83%
% of All Funds
2.36%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
15
Increased
43
Reduced
28
Closed
28
Calls
$430K
Puts
$327K
Net Calls
+$103K
Net Calls Change
+$184K

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$17.5M
2
VC
Vivo Capital
California
+$17M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$9.76M
4
Bank of America
Bank of America
North Carolina
+$5.31M
5
Deutsche Bank
Deutsche Bank
Germany
+$5.14M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$9.65M
2
FCM
Farallon Capital Management
California
-$8.06M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$6.45M
4
Morgan Stanley
Morgan Stanley
New York
-$5.53M
5
CAM
Cormorant Asset Management
Massachusetts
-$5.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
$2K -$19.3K -974 -87%
MAM
102
Meeder Asset Management
Ohio
$2K +$1.03K +52 +55%
Bank of Montreal
103
Bank of Montreal
Ontario, Canada
$1K -$73.7K -3,724 -99%
S
104
SignatureFD
Georgia
$1K – – –
TFS
105
TrustCore Financial Services
Tennessee
$1K – – –
SIS
106
Sound Income Strategies
Florida
$1K +$990 +50 New
FCM
107
Farallon Capital Management
California
– -$8.06M -354,082 Closed
PVI
108
Pura Vida Investments
New York
– -$2.48M -109,000 Closed
Millennium Management
109
Millennium Management
New York
– -$2.2M -96,702 Closed
CA
110
Corriente Advisors
Texas
– -$2.02M -88,927 Closed
Canada Pension Plan Investment Board
111
Canada Pension Plan Investment Board
Ontario, Canada
– -$1.75M -76,900 Closed
CS
112
Credit Suisse
Switzerland
– -$1.12M -49,289 Closed
JG
113
Jefferies Group
New York
– -$1.1M -48,277 Closed
MIM
114
Monashee Investment Management
Massachusetts
– -$951K -41,800 Closed
WCM
115
Weld Capital Management
New York
– -$922K -40,530 Closed
SSA
116
Schonfeld Strategic Advisors
New York
– -$829K -36,435 Closed
ECM
117
ExodusPoint Capital Management
New York
– -$707K -31,054 Closed
MS
118
Maven Securities
Jersey
– -$729K -31,000 Closed
APM
119
Avidity Partners Management
Texas
– -$683K -30,000 Closed
CSS
120
Cubist Systematic Strategies
Connecticut
– -$513K -22,525 Closed
ARTA
121
A.R.T. Advisors
New York
– -$457K -20,075 Closed
Squarepoint
122
Squarepoint
New York
– -$438K -19,262 Closed
WG
123
Winton Group
United Kingdom
– -$430K -18,882 Closed
ZCA
124
Zeke Capital Advisors
Pennsylvania
– -$417K -18,326 Closed
Rafferty Asset Management
125
Rafferty Asset Management
New York
– -$359K -15,783 Closed
2 3 4
5
6

RCKT Hedge Fund Activity: Q1 2020 in Review

107 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q1 2020, worth a combined $744M — down 37% from $1.18B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of RCKT and 15 opened new positions — a net loss of 13 holders — while 28 trimmed existing stakes and 43 added.

The largest buyer was Westfield Capital Management, adding an estimated $17.5M. The largest seller was Deerfield Management, cutting an estimated $9.65M.

  • 107 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q1 2020, down from 120 in Q4 2019.
  • Funds reported $744M of Rocket Pharmaceuticals stock for Q1 2020, down 37% quarter-over-quarter.
  • 15 funds opened new Rocket Pharmaceuticals positions in Q1 2020 and 28 closed out, a net change of -13 holders.
  • The largest Rocket Pharmaceuticals buyer in Q1 2020 was Westfield Capital Management, an estimated $17.5M added.
  • The largest Rocket Pharmaceuticals seller in Q1 2020 was Deerfield Management, an estimated $9.65M sold.

Based on aggregated 13F filings for Q1 2020.